VENOME® Succinate Amber Hydro 0.55% (1 x 3 mL) | Venome Global
Short Description
A cellular redermalizer and tissue biostimulator pairing High-Molecular-Weight Non-Cross-Linked Hyaluronic Acid (0.55%) with Sodium Succinate (Succinic Acid). Packaged in a 3 mL sterile clinical vial, Venome® Amber Hydro accelerates intracellular Krebs-cycle ATP synthesis, stimulates microvascular oxygenation, neutralizes free radicals, and replenishes deep moisture to restore elasticity, brighten dyschromia, and eliminate dark periorbital circles without post-treatment edema.
Detailed Description
VENOME® Succinate Amber Hydro 0.55% is an advanced physiological biostimulator developed by Venome Global, engineered around the concept of Redermalization. Rather than providing passive surface hydration alone, Amber Hydro targets cellular hypoxia and metabolic sluggishness within the extracellular matrix (ECM) to reactivate dormant cutaneous tissues.
The formulation operates through a complementary dual-mechanism pathway:
-
Sodium Succinate (Succinic Acid / Krebs Cycle Catalyst): Succinic acid is an intracellular metabolic intermediate required for mitochondrial cellular respiration. By acting directly on complex II of the electron transport chain, it increases cellular ATP synthesis, accelerates transmembrane ion exchange, and enhances tissue oxygenation. This metabolic boost enables stressed or senescent fibroblasts to actively synthesize native collagen and elastin. Furthermore, succinate provides potent antioxidant protection against reactive oxygen species (ROS) and activates microvascular and lymphatic drainage, clearing accumulated interstitial fluid and toxic metabolites.
-
High-Molecular-Weight Hyaluronic Acid (0.55% / Non-Cross-Linked): Uncross-linked, pure physiological sodium hyaluronate creates a viscoelastic, non-inflammatory extracellular environment that restores optimal interstitial osmotic balance. It provides immediate tissue turgor, locks water molecules within dermal layers, and acts as a transport conduit that facilitates the intracellular delivery of succinate ions to dermal fibroblasts.
Together, the two components counteract tissue hypoxia, quiet local inflammatory cascades, stimulate microcirculation, and restore natural skin brightness.
Treatment Areas & Indications
-
Periorbital Rejuvenation (Tear Troughs & Eyelids):
-
Vascular and pigmentary dark circles beneath the eyes
-
Periorbital lymphatic stagnation, puffiness, and fine dehydration crinkles
-
Thinning, transparent lower eyelid skin
-
-
Full-Face Biorevitalization & Sallow Complexion:
-
Hypoxic, dull, grayish, or “smoker’s skin” lacking microcirculatory flush
-
Uneven skin tone, superficial dyschromia, and photo-induced pigmentation
-
Loss of dermal elasticity, turgor, and overall skin fatigue
-
-
Delicate & Crepey Anatomical Zones:
-
Neck horizontal lines (“necklace bands”) and décolletage solar elastosis
-
Thinning dorsal hand tissue and loss of dermal fullness
-
-
Scar & Tissue Regeneration Support:
-
Post-inflammatory erythema (PIE) and atrophic post-acne scarring
-
Striae distensae (stretch marks) and slow-healing tissue trauma
-
Key Clinical Advantages
-
True Redermalization without Swelling: Delivers physiological hydration and cellular energization with minimal water retention or prolonged hydrophilic swelling, making it safe for delicate periorbital placement.
-
Mitochondrial ATP Upregulation: Directly addresses the energetic exhaustion of aging dermal cells by fueling the Krebs cycle, yielding a healthier fibroblast turnover.
-
Potent Microcirculatory & Lymphatic Decongestion: Stimulates capillary perfusion and lymphatic outflow, making it effective for treating blue/purple vascular eye rings and sluggish tissue.
-
Anti-Inflammatory & Barrier Soothing: Calms hyper-reactive vascular skin, rosacea-prone skin, and post-procedure erythema without triggering histamine responses.
-
Zero Downtime Protocol: Patients typically experience resolution of micro-papules within 24 to 48 hours, leaving skin noticeably brighter and firmer.
Technical Specifications
| Parameter | Specification |
| Product Classification | Redermalizing Tissue Biostimulator / Mesotherapy Solution |
| Manufacturer / Brand | Venome Global |
| Active Ingredients | Sodium Succinate (Succinic Acid) + High-Molecular Sodium Hyaluronate (0.55%) |
| HA Molecular Structure | Linear, high-molecular-weight, non-cross-linked physiological HA |
| Packaging Presentation | 1 x 3.0 mL sterile amber glass multidose vial |
| Lidocaine Content | Lidocaine-free (compatible with topical anesthetics) |
| Target Application Layer | Papillary dermis, epidermal-dermal junction, or superficial reticular dermis (0.5 mm to 1.5 mm depth) |
| Recommended Delivery Tools | 32G / 34G (4 mm) micro-needles, multi-needle injectors, or microneedling pens |
| Application Techniques | Micro-papular intradermal boluses (0.02–0.05 mL per point, 0.5–1 cm grid), nappage, or cannula fanning (27G/30G) |
| Recommended Treatment Protocol | Induction: 4 to 6 sessions spaced 7 to 14 days apart; Maintenance: 1 session every 3 to 6 months |
| Storage Instructions | Store between 2°C and 25°C (36°F to 77°F); protect from direct sunlight and freezing |
| Regulatory Category | Professional Aesthetic Product / Clinic-Use Only |
Professional Advisory: VENOME® Succinate Amber Hydro 0.55% is a professional-grade mesotherapy biostimulator intended strictly for credentialed dermatologists, plastic surgeons, and aesthetic practitioners trained in intradermal injection techniques. It is not formulated for intravascular or deep structural bolus administration.






Reviews
There are no reviews yet.